Rockwell Medical, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 61.47 | -100% | -1.72 | -100% |
| P/S |
|
0.5272 | 33.58 | -98.43% |
|
|
| P/BV |
|
2.07 | 4.79 | -56.8% |
|
|
| P/FCF |
|
-2.58 | 61 | -104.23% |
|
|
| Ev/Ebitda |
|
-9.29 | -17.26 | -46.19% |
|
|
| Ev/S |
|
0.5805 | 22.5 | -97.42% |
|
|
| Ev/FCF |
|
-2.2 | 69 | -103.19% |
|
|
| E/P |
|
-0.1483 | 0.0178 | -934.38% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-6.25 | 4.97 | -225.71% | -34.27 | -81.76% |
| ROE |
|
-39.64 | 9.61 | -512.38% |
|
|
| ROA |
|
-16.18 | 0.3443 | -4798.5% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-10.09 | -25.17 | -59.91% |
|
|
| ROCE |
|
-31.33 | 15.19 | -306.29% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-2 | -3.67 | -45.34% | -1.74 | +15.05% |
| Nеt Debt/Ebitda |
|
-0.8527 | -4.06 | -78.99% |
|
|
| Debt/Ratio |
|
0.2008 | 0.199 | 0.8959% |
|
|
| Debt/Equity |
|
0.2968 | 1.54 | -80.77% |
|
|
| Debt/Net Income |
|
-1.24 | 10.34 | -112% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5399 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2256 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9598 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4928 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5399 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
5/10
|
36.39 | 76.2 | -52.24% | ||
| Growth impulse Ebitda in 5 years |
|
-86.24 | 44.75 | -292.72% | ||
| Growth impulse Net Income in 5 years |
|
-73.19 | -15.36 | 376.5% | ||
| Growth impulse FCF in 5 years |
|
-66.09 | -108.72 | -39.21% | ||
| Growth impulse EPS in 5 years |
|
-93.63 | -142.05 | -34.09% |
IP Score
3.38/10
